BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32721992)

  • 1. Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity.
    Vidaña B; Martínez-Orellana P; Martorell JM; Baratelli M; Martínez J; Migura-Garcia L; Córdoba L; Pérez M; Casas I; Pozo F; Fraile L; Majó N; Montoya M
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32721992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.
    Abed Y; Pizzorno A; Bouhy X; Rhéaume C; Boivin G
    J Virol; 2014 Feb; 88(3):1652-8. PubMed ID: 24257597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.
    Butler J; Hooper KA; Petrie S; Lee R; Maurer-Stroh S; Reh L; Guarnaccia T; Baas C; Xue L; Vitesnik S; Leang SK; McVernon J; Kelso A; Barr IG; McCaw JM; Bloom JD; Hurt AC
    PLoS Pathog; 2014 Apr; 10(4):e1004065. PubMed ID: 24699865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    Kwon JJ; Choi WS; Jeong JH; Kim EH; Lee OJ; Yoon SW; Hwang J; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Gen Virol; 2018 Mar; 99(3):292-302. PubMed ID: 29493493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
    Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
    J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea.
    Kwon D; Shin K; Kim SJ; Lee JY; Kang C
    Virus Res; 2014 Jun; 185():41-6. PubMed ID: 24657788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets.
    Govorkova EA; Marathe BM; Prevost A; Rehg JE; Webster RG
    Antiviral Res; 2011 Aug; 91(2):81-8. PubMed ID: 21635924
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
    Hamelin ME; Baz M; Bouhy X; Beaulieu E; Dubé K; Mallett C; Boivin G
    Antivir Ther; 2011; 16(5):775-9. PubMed ID: 21817200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
    Hurt AC; Nor'e SS; McCaw JM; Fryer HR; Mosse J; McLean AR; Barr IG
    J Virol; 2010 Sep; 84(18):9427-38. PubMed ID: 20631138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
    Hamelin ME; Baz M; Abed Y; Couture C; Joubert P; Beaulieu E; Bellerose N; Plante M; Mallett C; Schumer G; Kobinger GP; Boivin G
    PLoS Pathog; 2010 Jul; 6(7):e1001015. PubMed ID: 20661429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models.
    Abed Y; Tu V; Carbonneau J; Checkmahomed L; Venable MC; Fage C; Marie-Ève-Hamelin ; Dufresne SF; Kobinger G; Boivin G
    Antiviral Res; 2018 Nov; 159():26-34. PubMed ID: 30219318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.
    Duan S; Boltz DA; Seiler P; Li J; Bragstad K; Nielsen LP; Webby RJ; Webster RG; Govorkova EA
    PLoS Pathog; 2010 Jul; 6(7):e1001022. PubMed ID: 20686654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir.
    Tilmanis D; Koszalka P; Barr IG; Rossignol JF; Mifsud E; Hurt AC
    Antiviral Res; 2020 Aug; 180():104851. PubMed ID: 32544408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses.
    Baz M; Abed Y; Simon P; Hamelin ME; Boivin G
    J Infect Dis; 2010 Mar; 201(5):740-5. PubMed ID: 20100088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.